Lake Street Capital Markets LLC
08/27/2026 | Press release | Distributed by Public on 08/27/2026 11:56
Verrica Pharmaceuticals Inc. (VRCA) - Initiation of Coverage
Lake Street Capital Markets Analyst, Thomas Flaten, initiated coverage of Verrica Pharmaceuticals Inc. with a BUY rating and price target of $9 (VRCA-$9). Verrica Pharmaceuticals Inc., a dermatology therapeutics company, engages in the development and commercialization of medications for the treatment of dermatologic diseases in the United States.
Want to stay up-to-date with the latest at Lake Street? Subscribe to our mailing list!
NameEmail Address
Thanks for joining our mailing list.
Oops! Something went wrong while submitting the form.
Lake Street Capital Markets LLC published this content on August 27, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on August 27, 2026 at 17:56 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]